The prevalence of cancer in patients with Multiple Sclerosis (MS) who were under treatment with Natalizumab (Tysabri): A systematic review and meta-analysis

Background: To determine the pooled prevalence of cancer in subjects with multiple sclerosis (MS) who received Natalizumab. Methods: Two researchers systematically searched PubMed, Scopus, EMBASE, Web of Science, google scholar, and gray literature including references of the included studies. The s...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Amirreza Nasirzadeh, Reza Jahanshahi, Mahsa Ghajarzadeh, Aida Mohammadi, Mohammad Ali Sahraian, Abdorreza Naser Moghadasi
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Wolters Kluwer Medknow Publications 2023-01-01
Cyfres:	International Journal of Preventive Medicine
Pynciau:	multiple sclerosis neoplasm prevalence
Mynediad Ar-lein:	http://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2023;volume=14;issue=1;spage=114;epage=114;aulast=Nasirzadeh
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!